Literature DB >> 23157737

Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis.

Hui Chen1, Xingshun Qi, Chuangye He, Zhanxin Yin, Daiming Fan, Guohong Han.   

Abstract

INTRODUCTION: The relationship between the imbalance in pro- and anti-coagulant factors and portal vein thrombosis (PVT) in individuals with cirrhosis is unclear. The aim of this study was to determine whether the imbalance in pro- and anti-coagulant factors contributes to the development of PVT in cirrhotic patients.
MATERIALS AND METHODS: Blood samples were collected from 30 consecutive cirrhotic patients with PVT and 30 age-, sex-, and Child-Pugh score-matched cirrhotic patients without PVT (controls), and the plasma levels of coagulation factors II, V, VII, VIII, IX, X, XI and XII and of protein C (PC), protein S (PS) and antithrombin (AT) were analyzed. The ratios of pro- vs. anti-coagulant factors were further investigated.
RESULTS: The levels of pro- and anti-coagulant factors were not statistically different between the PVT and control groups. Similar results were obtained when the patients were divided according to Child-Pugh classification. No difference was observed for the ratios of pro- vs. anti-coagulant factors between the two groups but the ratios of factor II-to-PC and factor VII-to-PC which were significantly decreased in the PVT group. Most of the ratios did not reach statistical significance in each Child-Pugh category except the followings: factor VIII-to-PS, factor XII-to-PC and factor XII-to-PS in class A patients; factor II-to-PS, factor VII-to-PC and factor VII-to-PS in class B patients. But the difference might not be so convincing.
CONCLUSIONS: PVT in cirrhotic patients may not result from coagulation imbalance.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23157737     DOI: 10.1016/j.thromres.2012.11.003

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  12 in total

1.  Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver.

Authors:  Roni Atalay; Reyhan Ersoy; Aylin Bolat Demirezer; Fatma Ebru Akın; Sefika Burcak Polat; Bekir Cakir; Osman Ersoy
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

2.  Portal vein thrombosis after hepatectomy.

Authors:  Shohei Yoshiya; Ken Shirabe; Hidekazu Nakagawara; Yuji Soejima; Tomoharu Yoshizumi; Toru Ikegami; Yo-Ichi Yamashita; Norifumi Harimoto; Akihiro Nishie; Takeharu Yamanaka; Yoshihiko Maehara
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

3.  Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.

Authors:  Martin Rössle; Michael Schultheiss
Journal:  J Transl Int Med       Date:  2018-03-28

Review 4.  Thrombotic Venous Diseases of the Liver.

Authors:  Timothy P Sabol; Marco Molina; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

5.  Imbalance of pro- vs. anti-coagulation factors in Chinese patients with Budd-Chiari syndrome and non-cirrhotic portal vein thrombosis.

Authors:  Hui Chen; Lei Liu; Xingshun Qi; Chuangye He; Zhanxin Yin; Feifei Wu; Daiming Fan; Guohong Han
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

6.  Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation.

Authors:  Hao-Chien Hung; Jin-Chiao Lee; Chih-Hsien Cheng; Yu-Chao Wang; Tsung-Han Wu; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Kun-Ming Chan; Wei-Chen Lee
Journal:  J Clin Med       Date:  2020-04-20       Impact factor: 4.241

Review 7.  Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View.

Authors:  Martin Rössle; Birke Bausch; Christoph Klinger
Journal:  Viszeralmedizin       Date:  2014-12

8.  Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cirrhosis Patients: A Randomized Controlled Trial.

Authors:  Rui Wang; Ming-Guang Zhang; Ou Luo; Liu He; Jia-Xin Li; Yun-Jing Tang; Yan-Li Luo; Min Zhou; Li Tang; Zong-Xia Zhang; Hao Wu; Xin-Zu Chen
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

9.  Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS.

Authors:  Hui Chen; Ming Bai; Xingshun Qi; Lei Liu; Chuangye He; Zhanxin Yin; Daiming Fan; Guohong Han
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.

Authors:  Irina Gîrleanu; Anca Trifan; Carol Stanciu; Cătălin Sfarti
Journal:  World J Gastroenterol       Date:  2018-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.